The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

Cellular immunotherapy specialist Fate Therapeutics soared as much as 73%, and closed up 12.45 at $2.27 yesterday, after it ...

Fate Therapeutics driven by positive Phase 1 Autoimmunity study results for its CAR T-cell therapy candidate FT819 in lupus ...

Long-term treatment with anifrolumab significantly reduced the rate of organ damage compared with SOC among patients with SLE ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; ...

A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...

according to a study published online Nov. 14 in the New England Journal of Medicine to coincide with the annual meeting of ...

The nonpartisan watchdog group American Oversight has been trying since last year to get the documents related to the sex-trafficking investigation into Matt Gaetz. The swift action, two weeks ...

Prosecutors have had to acknowledge that a victim frightened those around him. The defense lawyers are expected to paint their client as a protector. By Hurubie Meko and Anusha Bayya A developer ...

The first high level official meeting between Dhaka and New Delhi since the fall of Awami League government is scheduled to be held in Dhaka next month ...